VTYX - Ventyx Biosciences, Inc.

Price Target Consensus

14

Consensus Target

14

High Target

14

Median Target

14

Low Target

Price Target News & Updates

Date	Analyst	Company	Price Target	News Title
2026-01-08	N/A	Piper Sandler	$14	Ventyx Biosciences downgraded to Neutral from Overweight at Piper Sandler
2026-01-08	N/A	H.C. Wainwright	$14	Ventyx Biosciences downgraded to Neutral from Buy at H.C. Wainwright
2026-01-08	Michael Yee	UBS	$14	Ventyx Biosciences downgraded to Neutral from Buy at UBS
2026-01-08	Edward Nash	Canaccord Genuity	$14	Ventyx Biosciences downgraded to Hold from Buy at Canaccord
2026-01-07	N/A	UBS	$20	Ventyx Biosciences initiated with a Buy at UBS
2025-11-05	N/A	H.C. Wainwright	$18	Ventyx Biosciences upgraded to Buy from Neutral at H.C. Wainwright
2025-10-27	N/A	Oppenheimer	$14	Ventyx Biosciences price target raised to $14 from $9 at Oppenheimer
2024-06-13	Emily Bodnar	H.C. Wainwright	$6	H.C. Wainwright Maintains Ventyx Biosciences (VTYX) at Neutral, NT-0796 results…
2024-06-06	Jeff Jones	Oppenheimer	$10	Ventyx Biosciences Inc (VTYX) PT Lowered to $10 at Oppenheimer
2024-03-12	Derek Archila	Wells Fargo	$16	Wells Fargo Upgrades Ventyx Biosciences Inc (VTYX) to Overweight, 'We're Taking…